Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? The European Collaborative Study
Articolo
Data di Pubblicazione:
1999
Citazione:
Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight? The European Collaborative Study / A.E. Semprini, The European Colaborative Study. - In: AIDS. - ISSN 0269-9370. - 13:1(1999 Jan 14), pp. 119-124. [10.1097/00002030-199901140-00016]
Abstract:
Prophylactic zidovudine during pregnancy and labour reduces maternal viral load and, with neonatal therapy, has been shown to reduce vertical transmission. However, zidovudine may have additional effects. Advanced HIV disease is associated with premature delivery, which in turn results in increased vertical transmission. Data from the European Collaborative Study (ECS) were analysed to investigate whether zidovudine could be associated with decreased prematurity risk and/or with a reduced frequency of low birthweight.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Birthweight; Europe; Prematurity; Vertical transmission; Zidovudine
Elenco autori:
A.E. Semprini, T. European Colaborative Study
Link alla scheda completa: